Stocks and InvestingStocks and Investing
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022
Wed, March 30, 2022

Michael King Maintained (VINC) at Strong Buy with Increased Target to $28 on, Mar 30th, 2022


Published on 2024-10-27 20:13:57 - WOPRAI, Michael King
  Print publication without navigation


Michael King of HC Wainwright & Co., Maintained "Vincerx Pharma, Inc." (VINC) at Strong Buy with Increased Target from $25 to $28 on, Mar 30th, 2022.

Michael has made no other calls on VINC in the last 4 months.



There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • Li Watsek of "Cantor Fitzgerald" Initiated at Buy and Held Target at $25 on, Thursday, December 23rd, 2021